These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 1676394)

  • 1. Comparison of a B2 adrenergic agonist and an anticholinergic agent given by sequential inhalation in patients with severe chronic obstructive pulmonary disease.
    Heimer D; Brami JL; Liberman D; Bark H
    Isr J Med Sci; 1991 Jun; 27(6):307-10. PubMed ID: 1676394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients.
    Pillet O; Manier G; Castaing Y
    Monaldi Arch Chest Dis; 1998 Feb; 53(1):3-8. PubMed ID: 9632900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of domiciliary nebulizers in managing patients with severe COPD.
    Eiser N; Angus K; McHale S
    Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of aerosol oxitropium bromide and fenoterol on maximal exercise capacity in chronic obstructive pulmonary disease and their correlation with air flow during exercise and with parameters of maximal exercise].
    Suruda T; Nakamura H; Kobayashi H; Uetani K; Nishio M; Higashimoto Y; Funasako M; Ohata M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Sep; 31(9):1089-95. PubMed ID: 8255017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo-controlled comparison between the bronchodilatory effects of ipratropium bromide inhaled as a dry powder and by metered dose inhaler in chronic obstructive pulmonary disease.
    Gimeno F; van Veenen R; Berg WC; Steenhuis EJ
    Ann Allergy; 1988 Nov; 61(5):341-3. PubMed ID: 2973269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind comparison of tulobuterol and salbutamol in chronic obstructive pulmonary disease.
    Germouty J
    Clin Ther; 1986; 8(5):546-53. PubMed ID: 2876775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearance of lung secretions in patients with chronic bronchitis: effect of terbutaline and ipratropium bromide aerosols.
    Pavia D; Bateman JR; Sheahan NF; Clarke SW
    Eur J Respir Dis; 1980 Oct; 61(5):245-53. PubMed ID: 6451446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of ipratropium bromide to the bronchodilator test in patients with chronic obstructive pulmonary disease.
    Rodríguez-Carballeira M; Heredia JL; Gomez L; Quintana S; Vinas C
    Pulm Pharmacol Ther; 1999; 12(1):43-8. PubMed ID: 10447370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease.
    Newnham DM; Dhillon DP; Winter JH; Jackson CM; Clark RA; Lipworth BJ
    Thorax; 1993 Nov; 48(11):1151-5. PubMed ID: 8296260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of the bronchodilatating effects of ipratropium and terbutalin inhaled with Monaghan IPPB-M 515 by 19 patients with chronic obstructive airways disease.
    Petersen BN; Weeke E
    Scand J Respir Dis Suppl; 1979; 103():178-82. PubMed ID: 155295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease. A 90-day multi-center study.
    Tashkin DP; Ashutosh K; Bleecker ER; Britt EJ; Cugell DW; Cummiskey JM; DeLorenzo L; Gilman MJ; Gross GN; Gross NJ
    Am J Med; 1986 Nov; 81(5A):81-90. PubMed ID: 2947465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domiciliary nebulized terbutaline in severe chronic airways obstruction.
    Hansen NC; May O
    Eur Respir J; 1990 Apr; 3(4):463-4. PubMed ID: 2365041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchodilator responses to anticholinergic and beta-adrenergic agents in acute and stable COPD.
    Karpel JP
    Chest; 1991 Apr; 99(4):871-6. PubMed ID: 1672634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The muscarinic M1-receptor-selective antagonist, telenzepine, had no bronchodilatory effects in COPD patients.
    Ukena D; Wehinger C; Engelstätter R; Steinijans V; Sybrecht GW
    Eur Respir J; 1993 Mar; 6(3):378-82. PubMed ID: 8472828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a multicenter study of nebulized inhalant bronchodilator solutions.
    Tashkin DP; Bleecker E; Braun S; Campbell S; DeGraff AC; Hudgel DW; Boyars MC; Sahn S
    Am J Med; 1996 Jan; 100(1A):62S-69. PubMed ID: 8610720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of nebulised isotonic saline and terbutaline on breathlessness in severe chronic obstructive pulmonary disease (COPD).
    Poole PJ; Brodie SM; Stewart JM; Black PN
    Aust N Z J Med; 1998 Jun; 28(3):322-6. PubMed ID: 9673744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of a negative inhalation test in chronic obstructive lung disease].
    Derron M; Bachofen H
    Schweiz Med Wochenschr; 1975 May; 105(19):615-20. PubMed ID: 1153983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ipratropine and terbutaline. A comparative study of 19 patients with chronic obstructive lung diseases].
    Petersen BN; Weeke E
    Ugeskr Laeger; 1979 Sep; 141(36):2439-42. PubMed ID: 160643
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxitropium bromide improves exercise performance in patients with COPD.
    Ikeda A; Nishimura K; Koyama H; Sugiura N; Izumi T
    Chest; 1994 Dec; 106(6):1740-5. PubMed ID: 7988193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.